헬리코박터 파일로리 감염과 소화기 질환

키워드

참고문헌 (77)

1. McColl KE, "Clinical practice. Helicobacter pylori infection", N Engl J Med, 362, pp.1597~1604 (2010)
2. 정대영, "인간 위 속 헬리코박터 파이로리: 공생인가 질병인가?", 대한소화기학회지, 59(5), pp.329~337 (2012), 대한소화기학회[DOI]
3. Kim JH, "Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea", J Gastroenterol Hepatol, 16, pp.969~975 (2001)
4. Yim JY, "Seroprevalence of Helicobacter pylori in South Korea", Helicobacter, 12, pp.333~340 (2007)
5. Lim SH, "Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years", BMC Gastroenterol, 13, pp.104~ (2013)
6. 이주엽, "헬리코박터 제균 치료의 미래", 대한소화기학회지, 63(3), pp.158~170 (2014), 대한소화기학회
7. Kim N, "Helicobacter pylori" (2005), Medbook
8. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
9. International Agency for Research on Cancer, "Shistosomes, Liver Flukes and Helicobacter pylori. Vol. 61" (1994), International Agency for Research on Cancer
10. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer, "International Agency for Research on Cance", International Agency for Research on Cancer, ~, pp.IARC Working Group Reports 8 (2014)
11. Chow WH, "An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma", Cancer Res, 58, pp.588~590 (1998)
12. Kamangar F, "Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity", J Natl Cancer Inst, 98, pp.1445~1452 (2006)
13. Whiteman DC, "Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers", Gastroenterology, 139, pp.73~83.e11-12 (2010)
14. Ho KY, "Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country", Am J Gastroenterol, 100, pp.1923~1928 (2005)
15. Chen Y, "Helicobacter pylori colonization is inversely associated with childhood asthma", J Infect Dis, 198, pp.553~560 (2008)
16. Fujimoto Y, "Intrafamilial transmission of Helicobacter pylori among the population of endemic areas in Japan", Helicobacter, 12, pp.170~176 (2007)
17. Bansil R, "The Influence of Mucus Microstructure and Rheology in Helicobacter pylori Infection", Front Immunol, 4, pp.310~ (2013)
18. Montecucco C, "Living dangerously: how Helicobacter pylori survives in the human stomach", Nat Rev Mol Cell Biol, 2, pp.457~466 (2001)
19. Suerbaum S, "Helicobacter pylori infection", N Engl J Med, 347, pp.1175~1186 (2002)
20. Mégraud F, "A humble bacterium sweeps this year's Nobel Prize", Cell, 123, pp.975~976 (2005)
21. Isomoto H, "Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection", Am J Gastroenterol, 99, pp.1916~1923 (2004)
22. Makola D, "Helicobacter pylori infection and related gastrointestinal diseases", J Clin Gastroenterol, 41, pp.548~558 (2007)
23. Hunt RH, "Review article: should NSAID", low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing, 2004, pp.19(Suppl 1), 9~16
24. Sung JJ, "Systematic review: the global incidence and prevalence of peptic ulcer disease", Aliment Pharmacol Ther, 29, pp.938~946 (2009)
25. Manuel D, "Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications", Aliment Pharmacol Ther, 25, pp.1423~1427 (2007)
26. 방창석, "소화성 궤양의 합병증과 대책", Korean Journal of Helicobacter Upper Gastrointestinal Research, 14(1), pp.18~23 (2014), 대한상부위장관ㆍ헬리코박터학회[DOI]
27. Kim N, "Distribution of upper gastroduodenal diseases in health check-up subjects in 2006", Korean J Helicobacter Up Gastrointest Res, 8, pp.1~8 (2008)
28. 김진주, "2007년도 3차기관에서 진단된 소화성궤양 환자의 임상상", 대한소화기학회지, 59(5), pp.338~346 (2012), 대한소화기학회[DOI]
29. 김희선, "Prevalence of and Risk Factors for Gastrointestinal Diseases in Korean Americans and Native Koreans Undergoing Screening Endoscopy", Gut and Liver, 7(5), pp.539~545 (2013), 거트앤리버 발행위원회
30. 권정현, "Trends of Gastrointestinal Diseases at a Single Institution in Korea over the Past Two Decades", Gut and Liver, 3(4), pp.252~258 (2009), 거트앤리버 발행위원회
31. Kim JI, "Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005", Eur J Gastroenterol Hepatol, 21, pp.787~793 (2009)
32. Jang HJ, "Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study", Dig Dis Sci, 53, pp.1527~1531 (2008)
33. Meucci G, "Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter study", J Clin Gastroenterol, 31, pp.42~47 (2000)
34. Vu C, "Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital", Singapore Med J, 41, pp.478~481 (2000)
35. Kuipers EJ, "The prevalence of Helicobacter pylori in peptic ulcer disease", Aliment Pharmacol Ther, 9(Suppl 2), pp.59~69 (1995)
36. Ciociola AA, "Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated", Am J Gastroenterol, 94, pp.1834~1840 (1999)
37. Tsuji H, "Helicobacter pylorinegative gastric and duodenal ulcers", J Gastroenterol, 34, pp.455~460 (1999)
38. Borody TJ, "Helicobacter pylori-negative duodenal ulcer", Am J Gastroenterol, 86, pp.1154~1157 (1991)
39. Malfertheiner P, "Peptic ulcer disease", Lancet, 374, pp.1449~1461 (2009)
40. Huang JQ, "Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis", Lancet, 359, pp.14~22 (2002)
41. Papatheodoridis GV, "Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users", World J Gastroenterol, 11, pp.3811~3816 (2005)
42. Papatheodoridis GV, "Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review", Clin Gastroenterol Hepatol, 4, pp.130~142 (2006)
43. 김상균, "한국인 헬리코박터 파일로리 감염의 진단과 치료 임상 진료지침 개정안 2013", 대한소화기학회지, 62(1), pp.3~26 (2013), 대한소화기학회
44. 이준행, "비스테로이드소염제 관련 소화성궤양의 예방과 치료 가이드라인", 대한소화기학회지, 54(5), pp.309~317 (2009), 대한소화기학회
45. 정대영, "비출혈 소화성궤양 치료의 가이드라인", 대한소화기학회지, 54(5), pp.285~297 (2009), 대한소화기학회
46. Cancer incidence, "National Cancer Information Center", National Cancer Information Center, ~ (2015)
47. Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention", Cancer Res, 52, pp.6735~6740 (1992)
48. Ford AC, "Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials", BMJ, 348, pp.g3174~ (2014)
49. David Y. Graham, "Roadmap for elimination of gastric cancer in Korea", The Korean Journal of Internal Medicine, 30(2), pp.133~139 (2015), 대한내과학회[DOI]
50. Kim N, "Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease", Helicobacter, 13, pp.245~255 (2008)
51. van Grieken NC, "Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication", Digestion, 69, pp.27~33 (2004)
52. Wang J, "Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication:a meta-analysis", Digestion, 83, pp.253~260 (2011)
53. Kong YJ, "Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis", World J Gastroenterol, 20, pp.5903~5911 (2014)
54. Suzuki S, "Morphologic and histologic changes in gastric adenomas after Helicobacter pylori eradication: A long-term prospective analysis", Helicobacter, 20 (2015)
55. Ruskoné-Fourmestraux A, "EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT", Gut, 60, pp.747~758 (2011)
56. Eck M, "MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein", Gastroenterology, 112, pp.1482~1486 (1997)
57. Marshall BJ, "The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention", Med Clin North Am, 89, pp.313~344,viii (2005)
58. Fischbach W, "Gastric MALT lymphoma - update on diagnosis and treatment", Best Pract Res Clin Gastroenterol, 28, pp.1069~1077 (2014)
59. Fischbach W, "Gastric mucosal-associated lymphoid tissue lymphoma", Gastroenterol Clin North Am, 42, pp.371~380 (2013)
60. Nakamura S, "Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort followup study of 420 patients in Japan", Gut, 61, pp.507~513 (2012)
61. Chey WD, "Review article: uninvestigated dyspepsia and non-ulcer dyspepsia-the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy", Aliment Pharmacol Ther, 19(Suppl 1), pp.1~8 (2004)
62. El-Serag HB, "Systemic review: the prevalence and clinical course of functional dyspepsia", Aliment Pharmacol Ther, 19, pp.643~654 (2004)
63. Tack J, "Functional gastroduodenal disorders", Gastroenterology, 130, pp.1466~1479 (2006)
64. Miwa H, "Why dyspepsia can occur without organic disease:pathogenesis and management of functional dyspepsia", J Gastroenterol, 47, pp.862~871 (2012)
65. Jin X, "Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia", Helicobacter, 12, pp.541~546 (2007)
66. Turkkan E, "Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia?", J Gastroenterol, 44, pp.66~70 (2009)
67. Hidekazu Suzuki, "What Is the Difference Between Helicobacter pylori- Associated Dyspepsia and Functional Dyspepsia?", Journal of Neurogastroenterology and Motility (JNM), 17(2), pp.124~130 (2011), 대한소화기 기능성질환∙운동학회
68. Suzuki H, "Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?", J Gastroenterol Hepatol, 26(Suppl 3), pp.42~45 (2011)
69. Ford AC, "Helicobacter pylori “test and treat” or endoscopy for managing dyspepsia: an individual patient data meta-analysis", Gastroenterology, 128, pp.1838~1844 (2005)
70. El-Serag HB, "Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review", Gut, 63, pp.871~880 (2014)
71. Corley DA, "Helicobacter pylori and gastroesophageal reflux disease: a case-control study", Helicobacter, 13, pp.352~360 (2008)
72. Koike T, "Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion", Gut, 49, pp.330~334 (2001)
73. Vicari JJ, "The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease", Gastroenterology, 115, pp.50~57 (1998)
74. 김병창, "위식도역류질환의 임상 특징과 Helicobacter pylori 감염과의 상관관계", 대한소화기학회지, 47(5), pp.363~369 (2006), 대한소화기학회
75. 정수진, "Helicobacter pylori Serology Inversely Correlated With the Risk and Severity of Reflux Esophagitis in Helicobacter pylori Endemic Area: A Matched Case-Control Study of 5,616 Health Check-Up Koreans", Journal of Neurogastroenterology and Motility (JNM), 17(3), pp.267~273 (2011), 대한소화기 기능성질환∙운동학회
76. Nayoung Kim, "Effect of Helicobacter pylori Eradication on the Development of Refl ux Esophagitis and Gastroesophageal Refl ux Symptoms: A Nationwide Multi-Center Prospective Study", Gut and Liver, 5(4), pp.437~446 (2011), 거트앤리버 발행위원회
77. Malfertheiner P, "Management of Helicobacter pylori infection--the Maastricht IV", Florence Consensus Report, 2012, pp.61, 646~664

관련 논문AI추천